Intuitive Surgical, Inc.
NASDAQ:ISRG · NASDAQ Global Select
+$3.65 today
Vol 3.89M · Avg 2.21M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
16.0%
avg 14.1%
ROIC
13.7%
avg 12.7%
ROA
13.8%
avg 12.1%
Analysis
ROE is currently the strongest return metric at 16.0% versus its period average of 14.1%. 3 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
David J. Rosa | Chief Executive Officer & Director | $2.32M | — | 58 | $245,893.00 | 0.07% |
Gary S. Guthart | Executive Chair | $2.14M | — | 60 | $5,720.00 | <0.01% |
Jamie E. Samath | Executive VP, CFO & Enterprise Technology Leader | $1.48M | — | 55 | $20,709.00 | <0.01% |
Henry L. Charlton | Executive Vice President and Chief Commercial & Marketing Officer | $1.45M | — | 56 | $16,410.00 | <0.01% |
Gary Loeb | Executive Vice President and Chief Legal & Compliance Officer | $1.34M | — | 56 | $5,720.00 | <0.01% |
Mark Brosius | Executive VP and Chief Manufacturing & Supply Chain Officer | $1.02M | — | 59 | $1,406.00 | <0.01% |
Daniel Connally | Vice President & Head of Investor Relations | — | — | — | — | — |
Fredrik Widman | Vice President, Principal Accounting Officer & Corporate Controller | — | — | — | $1,026.00 | <0.01% |
Milind Wagle | Chief Information Officer | — | — | — | — | — |
Christopher R. Carlson | Executive Vice President of Research, Corporate Development, Corporate Strategy & Intuitive Ventures | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
30
$9.75M
Net Sentiment
$9.75M
Net selling
Most Active
Brosius Mark
15 transactions
1–10 of 30
Analysis
Insiders reported 0 buys worth $0.00 and 30 sells worth $9.75M over the last 12 months. That adds up to net selling of $9.75M. Brosius Mark was the most active insider with 15 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | -0.9% | +16.5% (15yr)4 analysts |
| Revenue | N/A | N/A | +3.1% | +14.7% (15yr)15 analysts |
| Net Income | N/A | N/A | -3.6% | +17.0% (15yr)15 analysts |
| EBIT | N/A | N/A | -5.5% | +14.5% (15yr)15 analysts |
Analysis
Recent growth has been strongest in Revenue at +3.1% over three years. Forward estimates point to Net Income at +17.0% (15yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Becton, Dickinson and Company
NYSE:BDX
$52.04B
ResMed Inc.
NYSE:RMD
$27.27B
West Pharmaceutical Services, Inc.
NYSE:WST
$23.11B
Hologic, Inc.
HOLX
$16.97B
The Cooper Companies, Inc.
NASDAQ:COO
$12.83B
Baxter International Inc.
NYSE:BAX
$10.27B
Repligen Corporation
NASDAQ:RGEN
$7.41B
Teleflex Incorporated
NYSE:TFX
$5.58B
Merit Medical Systems, Inc.
NASDAQ:MMSI
$4.01B
ICU Medical, Inc.
NASDAQ:ICUI
$3.52B
Embecta Corp.
NASDAQ:EMBC
$184.59M
Stereotaxis, Inc.
AMEX:STXS
$181.79M
Bionano Genomics, Inc.
BNGO
$13.43M
NEXGEL, Inc.
NXGL
$5.46M
Innovative Eyewear, Inc.
LUCY
$3.39M
Who manages ISRG?
Intuitive Surgical, Inc. (ISRG) lists 10 active executives. The top listed executive is Mark Brosius, Executive VP and Chief Manufacturing & Supply Chain Officer.
Are ISRG insiders buying or selling?
Recent insider activity shows net selling of $45.46M.
Explore More
Continue the stock analysis
Jump to another research area for this company.